Back

The shock factor: optimising antiplatelet therapy

28 August 2026 (10:20 - 10:29)
Organised by: Logo
Congress Presentation Part of: Rapid power, precise control: the evolving role of intravenous P2Y12 inhibition in chronic coronary syndromes, acute coronary syndromes, and cardiogenic shock Antiplatelet Agents Open Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Associate Professor Jolanta Siller-Matula

Medical University of Vienna, Vienna (Austria)

4 More presentations in this session

Presentation thumbnail
Opening address
Doctor P. Capranzano (Catania, IT)
Presentation thumbnail
The acute coronary syndrome challenge: speed as a priority in PCI
Professor D. Angiolillo (Jacksonville, US)
Presentation thumbnail
Tailoring IV antiplatelet therapy in chronic coronary syndromes
Associate Professor F. Pelliccia (Rome, IT)
Presentation thumbnail
Rapid power, precise control: the evolving role of intravenous P2Y12 inhibition in chronic coronary syndromes, acute coronary syndromes, and cardiogenic shock - discussion and Q&A

Access the full session

Session thumbnail
Rapid power, precise control: the evolving role of intravenous P2Y12 inhibition in chronic coronary syndromes, acute coronary syndromes, and cardiogenic shock

The Event

Event poster

ESC Congress 2026

28 August 2026 10:20 CET

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources